期刊
INFLAMMATION
卷 39, 期 1, 页码 16-29出版社
SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s10753-015-0218-x
关键词
asthma; airway remodeling; human bronchial smooth muscle cells; WISP1; TGF-beta
资金
- Chongqing Municipal Health Bureau
Upregulation of WISP1 has been demonstrated in lung remodeling. Moreover, it has been recently found that some signaling components of WNT pathway can activate GSK3 beta signaling to mediate remodeling of airway smooth muscle (ASM) in asthma. Therefore, we hypothesized that WISP1, a signaling molecule downstream of the WNT signaling pathway, is involved in PI3K/GSK3 beta signaling to mediate ASM remodeling in asthma. Our results showed that WISP1 depletion partly suppressed OVA-induced ASM hypertrophy in vivo. In vitro, WISP1 could induce hBSMC hypertrophy and proliferation, accompanied by upregulation of levels of PI3K, p-Akt, p-GSK3 beta, and its own expression. TGF-beta treatment could increase expression of PI3K, p-Akt, p-GSK3 beta, and WISP1. SH-5 treatment could partly suppress TGF-beta-induced hypertrophy and proliferation of hBSMC, and depress expression of p-GSK3 beta and WISP1. In conclusion, WISP1 may be a potential inducer of ASM proliferation and hypertrophy in asthma. The pro-remodeling effect of WISP1 is likely due to be involved in PI3K-GSK3 beta-dependent noncanonical TGF-beta signaling.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据